modelR05DA04

Extends from Pharmacokinetic.Models.PK_1C_enteral.

Information

name:Codeine
ATC code:R05DA04
route:oral
compartments:1
dosage:60mg
volume of distribution:3.6L
clearance:21L/h
other parameters in model implementation

Codeine is an opioid analgesic used for the relief of mild to moderate pain and as an antitussive to suppress cough. It is frequently combined with other analgesics such as paracetamol or ibuprofen. Codeine is still approved and used today in many countries, although its use is controlled due to potential for abuse and variable metabolism.

Pharmacokinetics

Pharmacokinetic parameters in healthy adult volunteers after oral administration of codeine phosphate.

References

  1. Thigpen, JC, et al., & Harirforoosh, S (2019). Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children. European journal of drug metabolism and pharmacokinetics 44(5) 591–609. DOI:10.1007/s13318-019-00552-0 PUBMED:https://pubmed.ncbi.nlm.nih.gov/31006834

  2. Gretler, SR, et al., & Knych, HK (2020). Metabolism, pharmacokinetics and selected pharmacodynamic effects of codeine following a single oral administration to horses. Veterinary anaesthesia and analgesia 47(5) 694–704. DOI:10.1016/j.vaa.2020.04.004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/32654915

  3. Knych, HK, et al., & McKemie, DS (2022). Pharmacokinetics, adverse effects and effects on thermal nociception following administration of three doses of codeine to horses. BMC veterinary research 18(1) 196–None. DOI:10.1186/s12917-022-03299-0 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35614473

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.TransferRateka (from PK_1C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_1C_enteral)600delay between oral administration and absorption (default 10min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)